Characterization of α1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity

European Journal of Pharmacology

Volumn 340, Issue 1, 1997, Pages 45-52

  Wada, Teiji ^a   Hasegawa, Yutaka ^a   Ono, Hideki ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

1 Adrenoceptor subtype; Motoneuron; Rat, adult; Spinal cord slice

Indexed keywords

2 (2 CHLORO 5 TRIFLUOROMETHYLPHENYLIMINO)IMIDAZOLIDINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 3,4,4A,5,10,10A HEXAHYDRO 6 METHOXY 4 METHYL 9 METHYLTHIO 2H NAPHTH[2,3 B][1,4]OXAZINE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE DERIVATIVE; CHLOROETHYLCLONIDINE; CLONIDINE; METHOXAMINE; NORADRENALIN; OXYMETAZOLINE; PHENYLEPHRINE; PRAZOSIN; RECEPTOR SUBTYPE; 5-METHYLURAPIDIL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIDGED COMPOUND; DIOXANE DERIVATIVE; DRUG DERIVATIVE; OXAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; SDZ NVI-085;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG COMPARISON; ELECTROPHYSIOLOGY; FACILITATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPINAL CORD MOTONEURON; ANIMAL; BINDING COMPETITION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTROSTIMULATION; METABOLISM; MOTONEURON; SPINAL CORD; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BINDING, COMPETITIVE; BRIDGED COMPOUNDS; CLONIDINE; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EPINEPHRINE; MALE; METHOXAMINE; MOTOR NEURONS; NOREPINEPHRINE; OXAZINES; PHENYLEPHRINE; PIPERAZINES; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; SPINAL CORD;

EID: 0031553128     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01406-4     Document Type: Article

References (32)

1. Andén N.-E., Jukes M.G., Lundberg A. The effect of DOPA on the spinal cord. 2. A pharmacological analysis. Acta Physiol. Scand. 67:1966;387-397.
2. 2D-adrenoceptors in rat lumbar spinal cord. J. Pharmacol. Exp. Ther. 269:1994;110-120.
3. 1B-adrenoceptor mediating contraction of the rat spleen. Br. J. Pharmacol. 115:1995;467-475.
4. Conway B.A., Hultborn H., Kiehn O., Mintz I. Plateau potentials in α-motoneurones induced by intravenous injection of L-DOPA and clonidine in the spinal cat. J. Physiol. 405:1988;369-384.
5. 1-adrenoceptor subtype mediating contraction of guinea-pig spleen. Eur. J. Pharmacol. 260:1994;211-220.
6. 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat. Eur. J. Pharmacol. 224:1992;125-136.
7. 1-adrenoceptor classification. Eur. J. Pharmacol. 268:1994;141-149.
8. 1-adrenoceptor subtypes in human and canine prostate membranes. J. Pharmacol. Exp. Ther. 271:1994;1228-1233.
9. 1-adrenoceptors. Eur. J. Pharmacol. 272:1995;R5-6.
10. 1-adrenoceptors: Consensus update. Pharmacol. Rev. 47:1995;267-270.
11. Hirayama T., Ono H., Fukuda H. Effects of adrenergic agents on ventral horn cells in rat spinal cord slices. Biomed. Res. 9:1988;343-351.
12. Hirayama T., Ono H., Fukuda H. Unit activity of ventral horn cells in spinal cord slices isolated from adult rats. Neurosci. Lett. 91:1988;343-348.
13. 1-adrenoceptor subtypes. Br. J. Pharmacol. 116:1995;1611-1618.
14. Hounsgaard J., Hultborn H., Jespersen B., Kiehn O. Bistability of alpha-motoneurones in the decerebrate cat and in the acute spinal cat after intravenous 5-hydroxytryptophan. J. Physiol. 405:1988;345-367.
15. 1-adrenergic mediated excitation of the flexor reflex in rats. J. Neurosci. 5:1985;1583-1590.
16. 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens. Br. J. Pharmacol. 111:1994;1003-1008.
17. McCall R.B., Aghajanian G.K. Serotonergic facilitation of facial motoneuron excitation. Brain Res. 169:1979;11-27.
18. 1A receptor agonists in the spontaneous tail-flick paradigm. J. Pharmacol. Exp. Ther. 269:1994;121-131.
19. 1-adrenergic receptor subtypes. Mol. Pharmacol. 46:1994;929-936.
20. 1-adrenoceptor agonists based on hexahydronaphth[2,3]1,4-oxazines and octahydrobenzo[g]quinolines. J. Med. Chem. 35:1992;480-489.
21. Ono H., Ono S., Fukuda H. 5-HT receptor-mediated regulation of thyrotropin-releasing hormone release in rat spinal cord. Eur. J. Pharmacol. 203:1991;283-285.
22. Ono H., Fukuda H. Pharmacology of descending noradrenergic systems in relation to motor function. Pharmacol. Ther. 68:1995;105-112.
23. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40:1991;876-883.
24. 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. Eur. J. Pharmacol. 205:1991;11-16.
25. 1-agonists, norepinephrine and clonidine, by selective antagonists of their subtypes in rabbit thoracic aorta. Jpn. J. Pharmacol. 60:1992;169-177.
26. 1C adrenergic receptor: Characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol. Pharmacol. 40:1991;619-626.
27. 2-adrenoceptors mediate facilitation and inhibition of spinal motor transmission, respectively. Jpn. J. Pharmacol. 54:1990;69-77.
28. 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci. 57:1995;L159-163.
29. 1-adrenoceptor subtypes in rat spinal cord. Eur. J. Pharmacol. 312:1996;263-266.
30. 1-adrenergic receptor subtypes in rat brain. J. Neurochem. 53:1989;1782-6178.
31. 1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices. Eur. J. Pharmacol. 220:1992;237-242.
32. Yamazaki J., Ono H., Nagao T. Stimulatory and inhibitory effects of serotonergic hallucinogens on spinal motoneuron and polysynaptic reflex pathways in the rat. Neuropharmacology. 31:1992;635-642.